Your browser doesn't support javascript.
loading
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL.
Moser, Russell; Annis, James; Nikolova, Olga; Whatcott, Cliff; Gurley, Kay; Mendez, Eduardo; Moran-Jones, Kim; Dorrell, Craig; Sears, Rosalie C; Kuo, Calvin; Han, Haiyong; Biankin, Andrew; Grandori, Carla; Von Hoff, Daniel D; Kemp, Christopher J.
Afiliação
  • Moser R; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Annis J; Quellos High Throughput Facility, Institute for Stem Cell and Regenerative Medicine, University of Washington Medicine Research, Seattle, Washington.
  • Nikolova O; Department of Computational Biology, Oregon Health and Science University, Portland, Oregon.
  • Whatcott C; Translational Genomics Research Institute, Molecular Medicine Division, Phoenix, Arizona.
  • Gurley K; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Mendez E; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Moran-Jones K; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Dorrell C; Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, Oregon.
  • Sears RC; Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, Oregon.
  • Kuo C; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.
  • Han H; Translational Genomics Research Institute, Molecular Medicine Division, Phoenix, Arizona.
  • Biankin A; Translational Genomics Research Institute, Molecular Medicine Division, Phoenix, Arizona.
  • Grandori C; SEngine Precision Medicine, Seattle, Washington.
  • Von Hoff DD; Translational Genomics Research Institute, Molecular Medicine Division, Phoenix, Arizona.
  • Kemp CJ; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cancer Res ; 82(18): 3375-3393, 2022 09 16.
Article em En | MEDLINE | ID: mdl-35819261
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2022 Tipo de documento: Article